We seek a healthier tomorrow

Ardy Arianpour is CEO & Co-Founder of Seqster, an award-winning SaaS healthcare platform that enables organizations to drive efficient healthcare via comprehensive medical records (EHR), individual genomic profiles (DNA), and personal health device data. For the first time, users create their own matched, longitudinal health data profile across all of their US-based healthcare data sources through person-centric interoperability. Ardy is a visionary health tech executive and serial entrepreneur in biotech and digital health.

Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and SVP of Ambry Genetics that sold to Konica for $1B in 2017. As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country.

Honored as a 2019 Top 40 Healthcare Transformer and San Diego Business Journal 40 under 40, Ardy earned a BS in Biological Sciences from the University of California Irvine and an MBA from Marshall Goldsmith School of Management.

Xiang (Sean) Li, CTO & Co-Founder, is a technology executive experienced at building and leading technical teams with expertise in clinical bioinformatics, data science, and software engineering. Dr. Li has a strong track record of delivering results by developing big-picture product strategies and following up with methodical execution. Previously, he was the Vice President of Clinical Bioinformatics at Pathway Genomics. Prior to that, he was the Director of Bioinformatics Development at Ambry Genetics where he led the implementation of the first commercial clinical exome sequencing test in 2011 and hereditary cancer panels based on next-gen sequencing. Dr. Li received his doctoral degrees in Bioinformatics from the University of Illinois, Chicago.

Dana Hosseini, CBO & Co-Founder, is a serial entrepreneur who has managed and co-founded a number of genomics-based companies including ProdermIQ, Iceland Genomics, and DiThera. Mr. Hosseini’s skills in international medical device and diagnostics sales and marketing were developed at Abbott Laboratories, OrthoClinical Diagnostics (Johnson & Johnson), and Sequenom where he held executive and management positions in business development, sales, and marketing functions. He has 25+ years of extensive experience working with big biotech and pharmaceutical companies globally. Dana received both his BS in Biochemistry and Genetics and MBA from the University of British Columbia.